UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000012514 |
|---|---|
| Receipt number | R000014648 |
| Scientific Title | A phase II study of Erlotinib Plus Bevacizumab in patients with advanced Non-squamous Non- Small Cell Lung Cancer with brain metastasis and Harboring Epidermal Growth Factor Receptor Mutations. |
| Date of disclosure of the study information | 2013/12/09 |
| Last modified on | 2017/06/10 13:53:01 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/12/07 15:02:18 | ||
| 2 | Update | 2014/06/09 09:59:09 | Email1 |
|
| 3 | Update | 2014/12/07 09:52:53 | Key inclusion criteria |
|
| 4 | Update | 2017/06/10 13:53:01 | Name of primary person or sponsor Organization |
